CONMED Corporation
CNMD
$34.03
-$0.74-2.13%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.31% | 7.88% | 6.70% | 3.09% | 2.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.31% | 7.88% | 6.70% | 3.09% | 2.88% |
| Cost of Revenue | -3.29% | 32.09% | 7.77% | 0.38% | 1.01% |
| Gross Profit | 0.22% | -10.44% | 5.88% | 5.27% | 4.37% |
| SG&A Expenses | 2.48% | 2.26% | 9.64% | 5.05% | 11.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.80% | 17.88% | 8.37% | 2.46% | 5.57% |
| Operating Income | -28.23% | -48.26% | -5.27% | 7.88% | -22.44% |
| Income Before Tax | 139.25% | -32.97% | -92.43% | -20.25% | -69.82% |
| Income Tax Expenses | 176.71% | 26.57% | -81.07% | 12.74% | -71.35% |
| Earnings from Continuing Operations | 129.09% | -50.41% | -94.16% | -28.54% | -69.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 129.09% | -50.41% | -94.16% | -28.54% | -69.37% |
| EBIT | -28.23% | -48.26% | -5.27% | 7.88% | -22.44% |
| EBITDA | -14.43% | -35.12% | -2.48% | 6.68% | -13.58% |
| EPS Basic | 131.97% | -50.49% | -94.18% | -28.85% | -69.56% |
| Normalized Basic EPS | -34.84% | -55.57% | -1.65% | 14.68% | -27.01% |
| EPS Diluted | 136.84% | -49.97% | -94.27% | -28.13% | -69.84% |
| Normalized Diluted EPS | -34.52% | -55.34% | -1.13% | 15.38% | -26.30% |
| Average Basic Shares Outstanding | -1.24% | 0.15% | 0.32% | 0.44% | 0.63% |
| Average Diluted Shares Outstanding | -1.70% | -0.37% | -0.20% | -0.17% | -0.39% |
| Dividend Per Share | -- | -100.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -- | 1.02% | 16.21% | 0.41% | 2.28% |